Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6063068 | Journal of Allergy and Clinical Immunology | 2014 | 8 Pages |
Abstract
We observed a significant decrease in the production of TH2 cytokines by PBMCs from patients who received SIT for TG allergy compared to those who did not. These changes might be used to monitor response to therapy. The decrease occurred in response to antigens that elicit little (if any) IgE responses; these antigens might be developed for use in immunotherapy.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Véronique PhD, Victoria BSc, John MSc, Jason PhD, April PhD, Rafeul MD, David MD, Bjoern PhD, Alessandro PhD,